Dr. Robert Gale ’66 will appear on a special edition of “20/20” at 10 p.m. ET Thursday, March 17, during ABC News’ “Disaster in the Pacific” coverage. A noted expert on leukemia and other bone marrow disorders, Gale will offer his perspective on the nuclear event that is occurring in Japan.
Gale has aided in several international nuclear incidents including coordinating all medical relief efforts for victims of Chernobyl in 1986, Goiania, Brazil in 1987 and Armenia in 1988. In 1999, he helped treat victims of the nuclear accident near Tokyo. Gale is an expert in radiation biology and has published more than 800 scientific articles and more than 20 books, mostly on leukemia, transplantation, cancer immunology and radiation, including biological effects and accident response.
On Tuesday, Gale conducted a brief WEOS radio interview with Professor of Economics Tom Drennen and his research student Joel Andruski ’11 concerning the nuclear power plant accidents in Japan. The interview is linked here.
For more than 35 years, Leukemia and other bone marrow disorders (such as aplastic anemia) have been the central theme of Gale’s basic scientific and clinical research. He and his colleagues have contributed to understanding the molecular biology and immunology of leukemia.
His interest and expertise in radiation biology stems from its causality of leukemia in humans and parallels between radiation-induced bone marrow failure and aplastic anemia. In the clinical research forum, Gale and his colleagues developed new drug-based therapies for acute myelogenous leukemia and studied efficacy of supportive care interventions including antibiotics, anti-fungals, granulocyte transfusions and molecularly-cloned hematopoietic growth factors.
Gale earned a B.A. in biology and chemistry, with Honors, from Hobart College, and his M.D. degree from the State University of New York at Buffalo. His postgraduate medical training (internal medicine, hematology and oncology) was at the University of California, Los Angeles (UCLA). Gale received a Ph.D. in microbiology and immunology from UCLA following doctoral work focusing on cancer immunology (with John Fahey). His postdoctoral studies at UCLA were funded by the U.S. National Institutes of Health (NIH) and the Leukemia Society of America, where he was the Bogart Fellow and Scholar.